nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—epilepsy syndrome	0.321	1	CbGaD
Aminosalicylic Acid—PTGS1—Diazepam—epilepsy syndrome	0.0541	0.559	CbGbCtD
Aminosalicylic Acid—PTGS1—Valproic Acid—epilepsy syndrome	0.0426	0.441	CbGbCtD
Aminosalicylic Acid—Methyldopa—ADRA2A—epilepsy syndrome	0.00106	0.256	CrCbGaD
Aminosalicylic Acid—CHUK—head—epilepsy syndrome	0.000983	0.0744	CbGeAlD
Aminosalicylic Acid—PTGS1—ganglion—epilepsy syndrome	0.000926	0.0701	CbGeAlD
Aminosalicylic Acid—CHUK—cerebellum—epilepsy syndrome	0.000877	0.0664	CbGeAlD
Aminosalicylic Acid—MPO—forebrain—epilepsy syndrome	0.000819	0.0619	CbGeAlD
Aminosalicylic Acid—CHUK—brain—epilepsy syndrome	0.000713	0.0539	CbGeAlD
Aminosalicylic Acid—Droxidopa—ADRA2A—epilepsy syndrome	0.000661	0.16	CrCbGaD
Aminosalicylic Acid—ALOX5—head—epilepsy syndrome	0.000554	0.0419	CbGeAlD
Aminosalicylic Acid—MPO—spinal cord—epilepsy syndrome	0.000527	0.0399	CbGeAlD
Aminosalicylic Acid—ALOX5—nervous system—epilepsy syndrome	0.000525	0.0397	CbGeAlD
Aminosalicylic Acid—ALOX5—central nervous system—epilepsy syndrome	0.000506	0.0383	CbGeAlD
Aminosalicylic Acid—Diflunisal—PTGS2—epilepsy syndrome	0.000503	0.122	CrCbGaD
Aminosalicylic Acid—ALOX5—cerebellum—epilepsy syndrome	0.000494	0.0374	CbGeAlD
Aminosalicylic Acid—MPO—head—epilepsy syndrome	0.000469	0.0355	CbGeAlD
Aminosalicylic Acid—Diflunisal—ALB—epilepsy syndrome	0.000448	0.108	CrCbGaD
Aminosalicylic Acid—MPO—nervous system—epilepsy syndrome	0.000444	0.0336	CbGeAlD
Aminosalicylic Acid—MPO—central nervous system—epilepsy syndrome	0.000428	0.0324	CbGeAlD
Aminosalicylic Acid—ALOX5—brain—epilepsy syndrome	0.000401	0.0304	CbGeAlD
Aminosalicylic Acid—Mesalazine—PTGS2—epilepsy syndrome	0.000395	0.0955	CrCbGaD
Aminosalicylic Acid—PTGS1—forebrain—epilepsy syndrome	0.000388	0.0294	CbGeAlD
Aminosalicylic Acid—PTGS2—forebrain—epilepsy syndrome	0.000371	0.0281	CbGeAlD
Aminosalicylic Acid—PTGS1—telencephalon—epilepsy syndrome	0.000357	0.027	CbGeAlD
Aminosalicylic Acid—PTGS2—telencephalon—epilepsy syndrome	0.000341	0.0258	CbGeAlD
Aminosalicylic Acid—MPO—brain—epilepsy syndrome	0.00034	0.0257	CbGeAlD
Aminosalicylic Acid—Hypersensitivity—Midazolam—epilepsy syndrome	0.000338	0.000979	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000337	0.000976	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000337	0.000976	CcSEcCtD
Aminosalicylic Acid—Flatulence—Valproic Acid—epilepsy syndrome	0.000337	0.000976	CcSEcCtD
Aminosalicylic Acid—Nausea—Clobazam—epilepsy syndrome	0.000337	0.000975	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Valproic Acid—epilepsy syndrome	0.000335	0.00097	CcSEcCtD
Aminosalicylic Acid—Anorexia—Lamotrigine—epilepsy syndrome	0.000335	0.000969	CcSEcCtD
Aminosalicylic Acid—Dizziness—Acetazolamide—epilepsy syndrome	0.000334	0.000967	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000334	0.000967	CcSEcCtD
Aminosalicylic Acid—Urticaria—Diazepam—epilepsy syndrome	0.000333	0.000966	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Clonazepam—epilepsy syndrome	0.000333	0.000965	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000332	0.000962	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Diazepam—epilepsy syndrome	0.000332	0.000961	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Phenytoin—epilepsy syndrome	0.000331	0.000958	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000331	0.000958	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000329	0.000953	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000329	0.000952	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000327	0.000947	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Gabapentin—epilepsy syndrome	0.000326	0.000943	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000325	0.000942	CcSEcCtD
Aminosalicylic Acid—Urticaria—Felbamate—epilepsy syndrome	0.000323	0.000935	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.000322	0.000931	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Felbamate—epilepsy syndrome	0.000321	0.00093	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Felbamate—epilepsy syndrome	0.000321	0.00093	CcSEcCtD
Aminosalicylic Acid—Vomiting—Acetazolamide—epilepsy syndrome	0.000321	0.00093	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Propofol—epilepsy syndrome	0.000321	0.000929	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Gabapentin—epilepsy syndrome	0.000319	0.000924	CcSEcCtD
Aminosalicylic Acid—Headache—Acetazolamide—epilepsy syndrome	0.000316	0.000916	CcSEcCtD
Aminosalicylic Acid—Anaemia—Valproic Acid—epilepsy syndrome	0.000316	0.000915	CcSEcCtD
Aminosalicylic Acid—Urticaria—Zonisamide—epilepsy syndrome	0.000316	0.000915	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000316	0.000915	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Zonisamide—epilepsy syndrome	0.000314	0.00091	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Zonisamide—epilepsy syndrome	0.000314	0.00091	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000314	0.00091	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000314	0.000909	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000313	0.000908	CcSEcCtD
Aminosalicylic Acid—Dizziness—Propofol—epilepsy syndrome	0.00031	0.000898	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Levetiracetam—epilepsy syndrome	0.00031	0.000898	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Topiramate—epilepsy syndrome	0.00031	0.000897	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.00031	0.000897	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Diazepam—epilepsy syndrome	0.000309	0.000896	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Pregabalin—epilepsy syndrome	0.000309	0.000895	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Valproic Acid—epilepsy syndrome	0.000306	0.000886	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000305	0.000884	CcSEcCtD
Aminosalicylic Acid—Flatulence—Pregabalin—epilepsy syndrome	0.000305	0.000882	CcSEcCtD
Aminosalicylic Acid—Urticaria—Clonazepam—epilepsy syndrome	0.000304	0.000882	CcSEcCtD
Aminosalicylic Acid—Dizziness—Midazolam—epilepsy syndrome	0.000304	0.000879	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000303	0.000878	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Clonazepam—epilepsy syndrome	0.000303	0.000877	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Clonazepam—epilepsy syndrome	0.000303	0.000877	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Pregabalin—epilepsy syndrome	0.000303	0.000877	CcSEcCtD
Aminosalicylic Acid—Urticaria—Phenytoin—epilepsy syndrome	0.000302	0.000876	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Phenytoin—epilepsy syndrome	0.000301	0.000872	CcSEcCtD
Aminosalicylic Acid—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000301	0.000871	CcSEcCtD
Aminosalicylic Acid—Nausea—Acetazolamide—epilepsy syndrome	0.0003	0.000869	CcSEcCtD
Aminosalicylic Acid—Dizziness—Levetiracetam—epilepsy syndrome	0.0003	0.000868	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000299	0.000867	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000299	0.000867	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000299	0.000867	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Topiramate—epilepsy syndrome	0.000299	0.000866	CcSEcCtD
Aminosalicylic Acid—L-DOPA—CYP2D6—epilepsy syndrome	0.000298	0.0722	CrCbGaD
Aminosalicylic Acid—Vomiting—Propofol—epilepsy syndrome	0.000298	0.000864	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000297	0.000861	CcSEcCtD
Aminosalicylic Acid—Rash—Propofol—epilepsy syndrome	0.000296	0.000857	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Propofol—epilepsy syndrome	0.000296	0.000856	CcSEcCtD
Aminosalicylic Acid—Headache—Propofol—epilepsy syndrome	0.000294	0.000851	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000293	0.000848	CcSEcCtD
Aminosalicylic Acid—Vomiting—Midazolam—epilepsy syndrome	0.000292	0.000845	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000292	0.000845	CcSEcCtD
Aminosalicylic Acid—Rash—Midazolam—epilepsy syndrome	0.000289	0.000838	CcSEcCtD
Aminosalicylic Acid—Dizziness—Fosphenytoin—epilepsy syndrome	0.000289	0.000838	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000289	0.000837	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Midazolam—epilepsy syndrome	0.000289	0.000837	CcSEcCtD
Aminosalicylic Acid—Urticaria—Carbamazepine—epilepsy syndrome	0.000289	0.000836	CcSEcCtD
Aminosalicylic Acid—Vomiting—Levetiracetam—epilepsy syndrome	0.000288	0.000835	CcSEcCtD
Aminosalicylic Acid—Headache—Midazolam—epilepsy syndrome	0.000288	0.000833	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000287	0.000832	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000287	0.000832	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Diazepam—epilepsy syndrome	0.000287	0.000832	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000287	0.000832	CcSEcCtD
Aminosalicylic Acid—Rash—Levetiracetam—epilepsy syndrome	0.000286	0.000828	CcSEcCtD
Aminosalicylic Acid—Anaemia—Pregabalin—epilepsy syndrome	0.000286	0.000827	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Levetiracetam—epilepsy syndrome	0.000286	0.000827	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Topiramate—epilepsy syndrome	0.000285	0.000825	CcSEcCtD
Aminosalicylic Acid—Headache—Levetiracetam—epilepsy syndrome	0.000284	0.000822	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Gabapentin—epilepsy syndrome	0.000284	0.000821	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000282	0.000818	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vigabatrin—epilepsy syndrome	0.000282	0.000817	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000281	0.000812	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—epilepsy syndrome	0.00028	0.0677	CrCbGaD
Aminosalicylic Acid—Flatulence—Gabapentin—epilepsy syndrome	0.000279	0.000809	CcSEcCtD
Aminosalicylic Acid—Urticaria—Lamotrigine—epilepsy syndrome	0.000279	0.000808	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000279	0.000808	CcSEcCtD
Aminosalicylic Acid—Nausea—Propofol—epilepsy syndrome	0.000279	0.000807	CcSEcCtD
Aminosalicylic Acid—Vomiting—Fosphenytoin—epilepsy syndrome	0.000278	0.000805	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Felbamate—epilepsy syndrome	0.000278	0.000805	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000278	0.000804	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000278	0.000804	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Gabapentin—epilepsy syndrome	0.000278	0.000804	CcSEcCtD
Aminosalicylic Acid—Dizziness—Diazepam—epilepsy syndrome	0.000278	0.000804	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Pregabalin—epilepsy syndrome	0.000277	0.000801	CcSEcCtD
Aminosalicylic Acid—Rash—Fosphenytoin—epilepsy syndrome	0.000276	0.000799	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000276	0.000798	CcSEcCtD
Aminosalicylic Acid—Headache—Fosphenytoin—epilepsy syndrome	0.000274	0.000794	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Topiramate—epilepsy syndrome	0.000274	0.000793	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000274	0.000793	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000273	0.000791	CcSEcCtD
Aminosalicylic Acid—Nausea—Midazolam—epilepsy syndrome	0.000273	0.000789	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Zonisamide—epilepsy syndrome	0.000272	0.000788	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vigabatrin—epilepsy syndrome	0.000271	0.000785	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Valproic Acid—epilepsy syndrome	0.000271	0.000785	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000271	0.000784	CcSEcCtD
Aminosalicylic Acid—Nausea—Levetiracetam—epilepsy syndrome	0.000269	0.00078	CcSEcCtD
Aminosalicylic Acid—Rash—Vigabatrin—epilepsy syndrome	0.000269	0.000779	CcSEcCtD
Aminosalicylic Acid—Dizziness—Felbamate—epilepsy syndrome	0.000269	0.000778	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Vigabatrin—epilepsy syndrome	0.000269	0.000778	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Topiramate—epilepsy syndrome	0.000269	0.000778	CcSEcCtD
Aminosalicylic Acid—PTGS2—medulla oblongata—epilepsy syndrome	0.000268	0.0203	CbGeAlD
Aminosalicylic Acid—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000268	0.000775	CcSEcCtD
Aminosalicylic Acid—Headache—Vigabatrin—epilepsy syndrome	0.000267	0.000774	CcSEcCtD
Aminosalicylic Acid—Vomiting—Diazepam—epilepsy syndrome	0.000267	0.000773	CcSEcCtD
Aminosalicylic Acid—Anorexia—Valproic Acid—epilepsy syndrome	0.000266	0.00077	CcSEcCtD
Aminosalicylic Acid—Rash—Diazepam—epilepsy syndrome	0.000265	0.000766	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Diazepam—epilepsy syndrome	0.000264	0.000766	CcSEcCtD
Aminosalicylic Acid—Dizziness—Zonisamide—epilepsy syndrome	0.000263	0.000762	CcSEcCtD
Aminosalicylic Acid—Headache—Diazepam—epilepsy syndrome	0.000263	0.000762	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Clonazepam—epilepsy syndrome	0.000262	0.000759	CcSEcCtD
Aminosalicylic Acid—Anaemia—Gabapentin—epilepsy syndrome	0.000262	0.000759	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000261	0.000757	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Phenytoin—epilepsy syndrome	0.00026	0.000754	CcSEcCtD
Aminosalicylic Acid—Nausea—Fosphenytoin—epilepsy syndrome	0.00026	0.000752	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000259	0.00075	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000259	0.000749	CcSEcCtD
Aminosalicylic Acid—Vomiting—Felbamate—epilepsy syndrome	0.000258	0.000748	CcSEcCtD
Aminosalicylic Acid—Rash—Felbamate—epilepsy syndrome	0.000256	0.000742	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Felbamate—epilepsy syndrome	0.000256	0.000741	CcSEcCtD
Aminosalicylic Acid—Headache—Felbamate—epilepsy syndrome	0.000255	0.000737	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Gabapentin—epilepsy syndrome	0.000254	0.000735	CcSEcCtD
Aminosalicylic Acid—Dizziness—Clonazepam—epilepsy syndrome	0.000253	0.000734	CcSEcCtD
Aminosalicylic Acid—Nausea—Vigabatrin—epilepsy syndrome	0.000253	0.000733	CcSEcCtD
Aminosalicylic Acid—Vomiting—Zonisamide—epilepsy syndrome	0.000253	0.000732	CcSEcCtD
Aminosalicylic Acid—Dizziness—Phenytoin—epilepsy syndrome	0.000252	0.000729	CcSEcCtD
Aminosalicylic Acid—Rash—Zonisamide—epilepsy syndrome	0.000251	0.000726	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Zonisamide—epilepsy syndrome	0.000251	0.000725	CcSEcCtD
Aminosalicylic Acid—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00025	0.000725	CcSEcCtD
Aminosalicylic Acid—PTGS1—spinal cord—epilepsy syndrome	0.00025	0.0189	CbGeAlD
Aminosalicylic Acid—Nausea—Diazepam—epilepsy syndrome	0.000249	0.000722	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ALB—epilepsy syndrome	0.000249	0.0603	CrCbGaD
Aminosalicylic Acid—Headache—Zonisamide—epilepsy syndrome	0.000249	0.000721	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000249	0.00072	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000247	0.000717	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000247	0.000715	CcSEcCtD
Aminosalicylic Acid—PTGS2—midbrain—epilepsy syndrome	0.000245	0.0185	CbGeAlD
Aminosalicylic Acid—Skin disorder—Pregabalin—epilepsy syndrome	0.000245	0.00071	CcSEcCtD
Aminosalicylic Acid—Vomiting—Clonazepam—epilepsy syndrome	0.000244	0.000706	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000243	0.000703	CcSEcCtD
Aminosalicylic Acid—Vomiting—Phenytoin—epilepsy syndrome	0.000242	0.000701	CcSEcCtD
Aminosalicylic Acid—Rash—Clonazepam—epilepsy syndrome	0.000242	0.0007	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Clonazepam—epilepsy syndrome	0.000241	0.000699	CcSEcCtD
Aminosalicylic Acid—Nausea—Felbamate—epilepsy syndrome	0.000241	0.000699	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000241	0.000698	CcSEcCtD
Aminosalicylic Acid—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000241	0.000697	CcSEcCtD
Aminosalicylic Acid—Anorexia—Pregabalin—epilepsy syndrome	0.000241	0.000696	CcSEcCtD
Aminosalicylic Acid—Dizziness—Carbamazepine—epilepsy syndrome	0.00024	0.000696	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Lamotrigine—epilepsy syndrome	0.00024	0.000696	CcSEcCtD
Aminosalicylic Acid—Headache—Clonazepam—epilepsy syndrome	0.00024	0.000695	CcSEcCtD
Aminosalicylic Acid—Rash—Phenytoin—epilepsy syndrome	0.00024	0.000695	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Phenytoin—epilepsy syndrome	0.00024	0.000694	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.00024	0.000694	CcSEcCtD
Aminosalicylic Acid—PTGS2—spinal cord—epilepsy syndrome	0.000239	0.0181	CbGeAlD
Aminosalicylic Acid—Rash—Oxcarbazepine—epilepsy syndrome	0.000239	0.000691	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000239	0.000691	CcSEcCtD
Aminosalicylic Acid—Headache—Phenytoin—epilepsy syndrome	0.000239	0.000691	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Topiramate—epilepsy syndrome	0.000239	0.000691	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ABCB1—epilepsy syndrome	0.000238	0.0576	CrCbGaD
Aminosalicylic Acid—Headache—Oxcarbazepine—epilepsy syndrome	0.000237	0.000687	CcSEcCtD
Aminosalicylic Acid—Nausea—Zonisamide—epilepsy syndrome	0.000236	0.000684	CcSEcCtD
Aminosalicylic Acid—Flatulence—Topiramate—epilepsy syndrome	0.000235	0.000681	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Topiramate—epilepsy syndrome	0.000234	0.000676	CcSEcCtD
Aminosalicylic Acid—Dizziness—Lamotrigine—epilepsy syndrome	0.000232	0.000673	CcSEcCtD
Aminosalicylic Acid—Vomiting—Carbamazepine—epilepsy syndrome	0.000231	0.000669	CcSEcCtD
Aminosalicylic Acid—Rash—Carbamazepine—epilepsy syndrome	0.000229	0.000664	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Carbamazepine—epilepsy syndrome	0.000229	0.000663	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000228	0.000661	CcSEcCtD
Aminosalicylic Acid—Nausea—Clonazepam—epilepsy syndrome	0.000228	0.000659	CcSEcCtD
Aminosalicylic Acid—Headache—Carbamazepine—epilepsy syndrome	0.000228	0.000659	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000227	0.000657	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000227	0.000656	CcSEcCtD
Aminosalicylic Acid—Nausea—Phenytoin—epilepsy syndrome	0.000226	0.000655	CcSEcCtD
Aminosalicylic Acid—Nausea—Oxcarbazepine—epilepsy syndrome	0.000225	0.000651	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Gabapentin—epilepsy syndrome	0.000225	0.000651	CcSEcCtD
Aminosalicylic Acid—Vomiting—Lamotrigine—epilepsy syndrome	0.000223	0.000647	CcSEcCtD
Aminosalicylic Acid—PTGS1—head—epilepsy syndrome	0.000222	0.0168	CbGeAlD
Aminosalicylic Acid—Urticaria—Valproic Acid—epilepsy syndrome	0.000222	0.000642	CcSEcCtD
Aminosalicylic Acid—Rash—Lamotrigine—epilepsy syndrome	0.000221	0.000641	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Lamotrigine—epilepsy syndrome	0.000221	0.000641	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000221	0.000639	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000221	0.000639	CcSEcCtD
Aminosalicylic Acid—Anorexia—Gabapentin—epilepsy syndrome	0.000221	0.000639	CcSEcCtD
Aminosalicylic Acid—Anaemia—Topiramate—epilepsy syndrome	0.00022	0.000638	CcSEcCtD
Aminosalicylic Acid—Headache—Lamotrigine—epilepsy syndrome	0.00022	0.000637	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Pregabalin—epilepsy syndrome	0.000219	0.000635	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000218	0.000631	CcSEcCtD
Aminosalicylic Acid—Nausea—Carbamazepine—epilepsy syndrome	0.000216	0.000625	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Topiramate—epilepsy syndrome	0.000213	0.000618	CcSEcCtD
Aminosalicylic Acid—PTGS2—head—epilepsy syndrome	0.000213	0.0161	CbGeAlD
Aminosalicylic Acid—PTGS1—nervous system—epilepsy syndrome	0.000211	0.016	CbGeAlD
Aminosalicylic Acid—Nausea—Lamotrigine—epilepsy syndrome	0.000209	0.000604	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000206	0.000597	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000206	0.000595	CcSEcCtD
Aminosalicylic Acid—PTGS1—central nervous system—epilepsy syndrome	0.000203	0.0154	CbGeAlD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000202	0.000584	CcSEcCtD
Aminosalicylic Acid—PTGS2—nervous system—epilepsy syndrome	0.000202	0.0152	CbGeAlD
Aminosalicylic Acid—Decreased appetite—Gabapentin—epilepsy syndrome	0.000201	0.000582	CcSEcCtD
Aminosalicylic Acid—Urticaria—Pregabalin—epilepsy syndrome	0.0002	0.00058	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.0002	0.000578	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Pregabalin—epilepsy syndrome	0.000199	0.000578	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Pregabalin—epilepsy syndrome	0.000199	0.000578	CcSEcCtD
Aminosalicylic Acid—PTGS2—central nervous system—epilepsy syndrome	0.000194	0.0147	CbGeAlD
Aminosalicylic Acid—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000191	0.000553	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Topiramate—epilepsy syndrome	0.000191	0.000553	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000191	0.000552	CcSEcCtD
Aminosalicylic Acid—PTGS2—cerebellum—epilepsy syndrome	0.00019	0.0143	CbGeAlD
Aminosalicylic Acid—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000189	0.000548	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Topiramate—epilepsy syndrome	0.000189	0.000548	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000186	0.000538	CcSEcCtD
Aminosalicylic Acid—Anorexia—Topiramate—epilepsy syndrome	0.000186	0.000537	CcSEcCtD
Aminosalicylic Acid—Dizziness—Valproic Acid—epilepsy syndrome	0.000185	0.000534	CcSEcCtD
Aminosalicylic Acid—Urticaria—Gabapentin—epilepsy syndrome	0.000184	0.000532	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Gabapentin—epilepsy syndrome	0.000183	0.00053	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Gabapentin—epilepsy syndrome	0.000183	0.00053	CcSEcCtD
Aminosalicylic Acid—Vomiting—Valproic Acid—epilepsy syndrome	0.000177	0.000514	CcSEcCtD
Aminosalicylic Acid—Rash—Valproic Acid—epilepsy syndrome	0.000176	0.00051	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Valproic Acid—epilepsy syndrome	0.000176	0.000509	CcSEcCtD
Aminosalicylic Acid—Headache—Valproic Acid—epilepsy syndrome	0.000175	0.000506	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Pregabalin—epilepsy syndrome	0.000173	0.0005	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Gabapentin—epilepsy syndrome	0.00017	0.000494	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Topiramate—epilepsy syndrome	0.000169	0.00049	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000168	0.000487	CcSEcCtD
Aminosalicylic Acid—Dizziness—Pregabalin—epilepsy syndrome	0.000167	0.000483	CcSEcCtD
Aminosalicylic Acid—Nausea—Valproic Acid—epilepsy syndrome	0.000166	0.00048	CcSEcCtD
Aminosalicylic Acid—PTGS1—brain—epilepsy syndrome	0.000161	0.0122	CbGeAlD
Aminosalicylic Acid—Vomiting—Pregabalin—epilepsy syndrome	0.00016	0.000465	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000159	0.000461	CcSEcCtD
Aminosalicylic Acid—Rash—Pregabalin—epilepsy syndrome	0.000159	0.000461	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Pregabalin—epilepsy syndrome	0.000159	0.00046	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Gabapentin—epilepsy syndrome	0.000158	0.000458	CcSEcCtD
Aminosalicylic Acid—Headache—Pregabalin—epilepsy syndrome	0.000158	0.000458	CcSEcCtD
Aminosalicylic Acid—Urticaria—Topiramate—epilepsy syndrome	0.000155	0.000448	CcSEcCtD
Aminosalicylic Acid—PTGS2—brain—epilepsy syndrome	0.000154	0.0117	CbGeAlD
Aminosalicylic Acid—Abdominal pain—Topiramate—epilepsy syndrome	0.000154	0.000446	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Topiramate—epilepsy syndrome	0.000154	0.000446	CcSEcCtD
Aminosalicylic Acid—Dizziness—Gabapentin—epilepsy syndrome	0.000153	0.000443	CcSEcCtD
Aminosalicylic Acid—Nausea—Pregabalin—epilepsy syndrome	0.00015	0.000434	CcSEcCtD
Aminosalicylic Acid—Vomiting—Gabapentin—epilepsy syndrome	0.000147	0.000426	CcSEcCtD
Aminosalicylic Acid—Rash—Gabapentin—epilepsy syndrome	0.000146	0.000422	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Gabapentin—epilepsy syndrome	0.000146	0.000422	CcSEcCtD
Aminosalicylic Acid—Headache—Gabapentin—epilepsy syndrome	0.000145	0.00042	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Topiramate—epilepsy syndrome	0.000143	0.000415	CcSEcCtD
Aminosalicylic Acid—Nausea—Gabapentin—epilepsy syndrome	0.000137	0.000398	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Topiramate—epilepsy syndrome	0.000133	0.000386	CcSEcCtD
Aminosalicylic Acid—Dizziness—Topiramate—epilepsy syndrome	0.000129	0.000373	CcSEcCtD
Aminosalicylic Acid—Vomiting—Topiramate—epilepsy syndrome	0.000124	0.000358	CcSEcCtD
Aminosalicylic Acid—Rash—Topiramate—epilepsy syndrome	0.000123	0.000355	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Topiramate—epilepsy syndrome	0.000123	0.000355	CcSEcCtD
Aminosalicylic Acid—Headache—Topiramate—epilepsy syndrome	0.000122	0.000353	CcSEcCtD
Aminosalicylic Acid—Nausea—Topiramate—epilepsy syndrome	0.000116	0.000335	CcSEcCtD
Aminosalicylic Acid—CHUK—Immune System—IL1RN—epilepsy syndrome	3.34e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—DUSP6—epilepsy syndrome	3.33e-05	0.000152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—TSC2—epilepsy syndrome	3.32e-05	0.000151	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	3.3e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—SRC—epilepsy syndrome	3.28e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ABCB1—epilepsy syndrome	3.28e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ASAH1—epilepsy syndrome	3.24e-05	0.000148	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—AKT1—epilepsy syndrome	3.23e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—AKT1—epilepsy syndrome	3.22e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—AKT1—epilepsy syndrome	3.2e-05	0.000146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—AKT1—epilepsy syndrome	3.18e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TXNRD1—epilepsy syndrome	3.18e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6ST—epilepsy syndrome	3.18e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GFAP—epilepsy syndrome	3.17e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GAL—epilepsy syndrome	3.17e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—STXBP1—epilepsy syndrome	3.15e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—epilepsy syndrome	3.14e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GRM5—epilepsy syndrome	3.13e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CHRM3—epilepsy syndrome	3.13e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP2—epilepsy syndrome	3.13e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40—epilepsy syndrome	3.12e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AQP1—epilepsy syndrome	3.09e-05	0.000141	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	3.08e-05	0.000141	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NT5E—epilepsy syndrome	3.07e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALAD—epilepsy syndrome	3.07e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PRKCB—epilepsy syndrome	3.06e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GPX1—epilepsy syndrome	3.05e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CX3CR1—epilepsy syndrome	3e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—AKT1—epilepsy syndrome	3e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—AKT1—epilepsy syndrome	3e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—epilepsy syndrome	3e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	3e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—AKT1—epilepsy syndrome	2.97e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.97e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CX3CL1—epilepsy syndrome	2.95e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CHRM2—epilepsy syndrome	2.95e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BDKRB1—epilepsy syndrome	2.95e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—AKT1—epilepsy syndrome	2.94e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HBEGF—epilepsy syndrome	2.94e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—AKT1—epilepsy syndrome	2.93e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	2.93e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	2.93e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FOS—epilepsy syndrome	2.91e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SLC2A1—epilepsy syndrome	2.88e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT3—epilepsy syndrome	2.88e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	2.87e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GABBR1—epilepsy syndrome	2.87e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—JUNB—epilepsy syndrome	2.86e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CASP8—epilepsy syndrome	2.84e-05	0.00013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS1—epilepsy syndrome	2.84e-05	0.00013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.82e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ADSL—epilepsy syndrome	2.81e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	2.8e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CHRM3—epilepsy syndrome	2.8e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—AKT1—epilepsy syndrome	2.77e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GLUL—epilepsy syndrome	2.75e-05	0.000126	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRH3—epilepsy syndrome	2.75e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HBEGF—epilepsy syndrome	2.71e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—OPRM1—epilepsy syndrome	2.7e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	2.7e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.69e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AGT—epilepsy syndrome	2.67e-05	0.000122	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—S100B—epilepsy syndrome	2.66e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT3—epilepsy syndrome	2.66e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—epilepsy syndrome	2.65e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SOCS3—epilepsy syndrome	2.64e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDC42—epilepsy syndrome	2.63e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOE—epilepsy syndrome	2.62e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.62e-05	0.000119	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.6e-05	0.000119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ADAM10—epilepsy syndrome	2.6e-05	0.000119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGF2—epilepsy syndrome	2.57e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR3—epilepsy syndrome	2.55e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.55e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	2.53e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EIF2AK2—epilepsy syndrome	2.49e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NPY—epilepsy syndrome	2.49e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ATP2A2—epilepsy syndrome	2.49e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGF2—epilepsy syndrome	2.47e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AQP1—epilepsy syndrome	2.45e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—BCL2—epilepsy syndrome	2.44e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDC42—epilepsy syndrome	2.43e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL18—epilepsy syndrome	2.4e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HSPB1—epilepsy syndrome	2.4e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL3—epilepsy syndrome	2.4e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CRH—epilepsy syndrome	2.4e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—OXT—epilepsy syndrome	2.4e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL2—epilepsy syndrome	2.4e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—RELA—epilepsy syndrome	2.38e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.36e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FYN—epilepsy syndrome	2.34e-05	0.000107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MTOR—epilepsy syndrome	2.34e-05	0.000107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MEF2C—epilepsy syndrome	2.33e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PPIA—epilepsy syndrome	2.31e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—epilepsy syndrome	2.3e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—RELA—epilepsy syndrome	2.29e-05	0.000104	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCG2—epilepsy syndrome	2.28e-05	0.000104	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—POMC—epilepsy syndrome	2.25e-05	0.000103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—YWHAZ—epilepsy syndrome	2.25e-05	0.000103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—MTOR—epilepsy syndrome	2.24e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.24e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTK2B—epilepsy syndrome	2.23e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TSC1—epilepsy syndrome	2.23e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HES1—epilepsy syndrome	2.22e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	2.22e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	2.22e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CHRM3—epilepsy syndrome	2.22e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	2.21e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.19e-05	0.0001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SST—epilepsy syndrome	2.17e-05	9.91e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR2—epilepsy syndrome	2.17e-05	9.91e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NTRK2—epilepsy syndrome	2.17e-05	9.91e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FYN—epilepsy syndrome	2.16e-05	9.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—H2AFX—epilepsy syndrome	2.15e-05	9.82e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—DUSP6—epilepsy syndrome	2.15e-05	9.82e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADRA2A—epilepsy syndrome	2.12e-05	9.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLAT—epilepsy syndrome	2.12e-05	9.65e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—JUN—epilepsy syndrome	2.09e-05	9.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—YWHAZ—epilepsy syndrome	2.08e-05	9.48e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.07e-05	9.43e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ALB—epilepsy syndrome	2.05e-05	9.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL12—epilepsy syndrome	2.04e-05	9.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BDKRB2—epilepsy syndrome	2.04e-05	9.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—epilepsy syndrome	2.04e-05	9.31e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.02e-05	9.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CRP—epilepsy syndrome	2.01e-05	9.18e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TSC2—epilepsy syndrome	2.01e-05	9.18e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JUNB—epilepsy syndrome	2e-05	9.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CNR1—epilepsy syndrome	2e-05	9.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CCR5—epilepsy syndrome	2e-05	9.12e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2e-05	9.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLCB1—epilepsy syndrome	2e-05	9.11e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	1.99e-05	9.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HTR7—epilepsy syndrome	1.96e-05	8.92e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HBEGF—epilepsy syndrome	1.9e-05	8.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	1.9e-05	8.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—BCHE—epilepsy syndrome	1.89e-05	8.62e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—SRC—epilepsy syndrome	1.87e-05	8.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT3—epilepsy syndrome	1.86e-05	8.5e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TSC2—epilepsy syndrome	1.86e-05	8.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PRKCB—epilepsy syndrome	1.86e-05	8.47e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6ST—epilepsy syndrome	1.85e-05	8.44e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADAM10—epilepsy syndrome	1.82e-05	8.3e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—epilepsy syndrome	1.82e-05	8.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCG2—epilepsy syndrome	1.81e-05	8.25e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	1.8e-05	8.22e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—SRC—epilepsy syndrome	1.8e-05	8.21e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—epilepsy syndrome	1.8e-05	8.19e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLCB1—epilepsy syndrome	1.78e-05	8.13e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TH—epilepsy syndrome	1.78e-05	8.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	1.76e-05	8.04e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	1.75e-05	7.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.75e-05	7.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.74e-05	7.94e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—S100B—epilepsy syndrome	1.72e-05	7.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC2A1—epilepsy syndrome	1.71e-05	7.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6ST—epilepsy syndrome	1.71e-05	7.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SOCS3—epilepsy syndrome	1.7e-05	7.77e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDC42—epilepsy syndrome	1.7e-05	7.76e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—JUNB—epilepsy syndrome	1.7e-05	7.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FOS—epilepsy syndrome	1.69e-05	7.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS2—epilepsy syndrome	1.69e-05	7.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS1—epilepsy syndrome	1.68e-05	7.68e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.67e-05	7.62e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CASP8—epilepsy syndrome	1.65e-05	7.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AVP—epilepsy syndrome	1.65e-05	7.51e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HBEGF—epilepsy syndrome	1.61e-05	7.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.59e-05	7.24e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	1.58e-05	7.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT3—epilepsy syndrome	1.58e-05	7.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HES1—epilepsy syndrome	1.56e-05	7.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ADAM10—epilepsy syndrome	1.54e-05	7.02e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FYN—epilepsy syndrome	1.51e-05	6.9e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—H2AFX—epilepsy syndrome	1.51e-05	6.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	1.51e-05	6.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MEF2C—epilepsy syndrome	1.51e-05	6.87e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—BCHE—epilepsy syndrome	1.5e-05	6.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGF2—epilepsy syndrome	1.5e-05	6.82e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HMOX1—epilepsy syndrome	1.48e-05	6.76e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CAT—epilepsy syndrome	1.46e-05	6.67e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—YWHAZ—epilepsy syndrome	1.45e-05	6.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NGF—epilepsy syndrome	1.44e-05	6.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDC42—epilepsy syndrome	1.44e-05	6.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	1.43e-05	6.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCB1—epilepsy syndrome	1.42e-05	6.49e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2—epilepsy syndrome	1.42e-05	6.48e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLCB1—epilepsy syndrome	1.41e-05	6.45e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TH—epilepsy syndrome	1.41e-05	6.43e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR5—epilepsy syndrome	1.4e-05	6.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RELA—epilepsy syndrome	1.39e-05	6.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGF2—epilepsy syndrome	1.38e-05	6.3e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HTR2A—epilepsy syndrome	1.37e-05	6.25e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MTOR—epilepsy syndrome	1.36e-05	6.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GPX1—epilepsy syndrome	1.32e-05	6.03e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HES1—epilepsy syndrome	1.32e-05	6.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TSC2—epilepsy syndrome	1.3e-05	5.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AGT—epilepsy syndrome	1.3e-05	5.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FYN—epilepsy syndrome	1.28e-05	5.84e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—H2AFX—epilepsy syndrome	1.28e-05	5.82e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—epilepsy syndrome	1.27e-05	5.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTOR—epilepsy syndrome	1.26e-05	5.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1B—epilepsy syndrome	1.26e-05	5.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KDR—epilepsy syndrome	1.25e-05	5.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—epilepsy syndrome	1.25e-05	5.68e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—YWHAZ—epilepsy syndrome	1.23e-05	5.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—JUN—epilepsy syndrome	1.22e-05	5.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRKCB—epilepsy syndrome	1.2e-05	5.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6ST—epilepsy syndrome	1.2e-05	5.46e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CCR5—epilepsy syndrome	1.18e-05	5.4e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HMOX1—epilepsy syndrome	1.18e-05	5.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—epilepsy syndrome	1.16e-05	5.31e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CAT—epilepsy syndrome	1.16e-05	5.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AGT—epilepsy syndrome	1.16e-05	5.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—epilepsy syndrome	1.14e-05	5.18e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCB1—epilepsy syndrome	1.13e-05	5.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—epilepsy syndrome	1.12e-05	5.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TSC2—epilepsy syndrome	1.1e-05	5.02e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—POMC—epilepsy syndrome	1.09e-05	4.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SRC—epilepsy syndrome	1.09e-05	4.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—epilepsy syndrome	1.08e-05	4.91e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL2—epilepsy syndrome	1.07e-05	4.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPX1—epilepsy syndrome	1.05e-05	4.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6ST—epilepsy syndrome	1.01e-05	4.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SRC—epilepsy syndrome	1.01e-05	4.6e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS2—epilepsy syndrome	1e-05	4.58e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—POMC—epilepsy syndrome	9.76e-06	4.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF2—epilepsy syndrome	9.67e-06	4.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AGT—epilepsy syndrome	9.2e-06	4.2e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—epilepsy syndrome	9.02e-06	4.12e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—epilepsy syndrome	9.02e-06	4.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RELA—epilepsy syndrome	8.98e-06	4.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—epilepsy syndrome	8.9e-06	4.06e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MTOR—epilepsy syndrome	8.8e-06	4.02e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF2—epilepsy syndrome	8.18e-06	3.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—epilepsy syndrome	8.1e-06	3.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JUN—epilepsy syndrome	7.86e-06	3.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—epilepsy syndrome	7.78e-06	3.55e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—POMC—epilepsy syndrome	7.75e-06	3.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—epilepsy syndrome	7.65e-06	3.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTOR—epilepsy syndrome	7.45e-06	3.4e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—epilepsy syndrome	7.06e-06	3.22e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SRC—epilepsy syndrome	7.05e-06	3.22e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—epilepsy syndrome	6.87e-06	3.13e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—epilepsy syndrome	6.78e-06	3.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—epilepsy syndrome	6.26e-06	2.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SRC—epilepsy syndrome	5.97e-06	2.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—epilepsy syndrome	4.38e-06	2e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—epilepsy syndrome	3.91e-06	1.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—epilepsy syndrome	3.71e-06	1.69e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—epilepsy syndrome	3.11e-06	1.42e-05	CbGpPWpGaD
